CONMED Corporation (CNMD): A Bull Case Theory [Yahoo! Finance]
CONMED Corporation (CNMD)
Last conmed corporation earnings: 4/29 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
conmed.com/en/about-us/investors/investor-relations
Company Research
Source: Yahoo! Finance
CONMED Corporation's share was trading at $46.00 as of September 26th. CNMD's trailing P/E was 12.99 according to Yahoo Finance. 10 Most Competitive Medical Fellowships in America egyjanek/Shutterstock.com Conmed Corporation (CONMED) is a global medical device company focused on enabling less invasive and more effective surgery across orthopedics, general surgery, gastroenterology, gynecology, and thoracic procedures. Founded in 1970, Conmed expanded through acquisitions and internal R&D, with key milestones including the 1990s purchase of Linvatec, establishing a foothold in arthroscopy and sports medicine, and the 2019 acquisition of Buffalo Filter, positioning it as a leader in surgical smoke evacuation—a market boosted by robotic and minimally invasive surgery. In 2024, Conmed generated roughly $1.3 billion in revenue, split between orthopedic surgery (~42%) and general surgery (~58%). The orthopedic segment includes implants, instruments, and extremity products, with 79%
Show less
Read more
Impact Snapshot
Event Time:
CNMD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CNMD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CNMD alerts
High impacting CONMED Corporation news events
Weekly update
A roundup of the hottest topics
CNMD
News
- CONMED Corporation Announces Strategic Exit from Gastroenterology Product LinesBusiness Wire
- CONMED (NYSE:CNMD) had its price target lowered by analysts at JPMorgan Chase & Co. from $58.00 to $52.00. They now have a "neutral" rating on the stock.MarketBeat
- CONMED (NYSE:CNMD) had its price target lowered by analysts at Piper Sandler from $68.00 to $55.00. They now have an "overweight" rating on the stock.MarketBeat
- CONMED (NYSE:CNMD) had its price target lowered by analysts at Wells Fargo & Company from $57.00 to $47.00. They now have an "equal weight" rating on the stock.MarketBeat
- Conmed Corp (CNMD) Q3 2025 Earnings Call Highlights: Strong Sales Growth Amidst Margin Challenges [Yahoo! Finance]Yahoo! Finance
CNMD
Earnings
- 11/5/25 - Beat
CNMD
Sec Filings
- 12/5/25 - Form 8-K
- 11/24/25 - Form 4
- 11/21/25 - Form 4
- CNMD's page on the SEC website